UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas

Modern pathology, 2022-07, Vol.35 (7), p.962-971

2022

Volltextzugriff (PDF)

Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer

Scientific reports, 2022-01, Vol.12 (1), p.974-974, Article 974

2022

Volltextzugriff (PDF)

The highs and lows of serous ovarian cancer

Cancer, 2023-09, Vol.129 (17), p.2613-2620

2023

Volltextzugriff (PDF)

Characterization of TP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinoma

Modern pathology, 2021-02, Vol.34 (2), p.490-501

2021

Volltextzugriff (PDF)

Beyond the estrogen receptor: In search of predictive biomarkers for low‐grade serous ovarian cancer

Cancer, 2023-05, Vol.129 (9), p.1305-1307

2023

Volltextzugriff (PDF)

Chemotherapy response in low‐grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies

Cancer, 2023-07, Vol.129 (13), p.2004-2012

2023

Volltextzugriff (PDF)

Decreased HER2 expression in endometrial cancer following anti-HER2 therapy

The Journal of pathology, 2024-02, Vol.262 (2), p.129-136

2024

Volltextzugriff (PDF)

Multi-Institutional Prospective Validation of Prognostic mRNA Signatures in Early Stage Squamous Lung Cancer (Alliance)

Journal of thoracic oncology, 2020-11, Vol.15 (11), p.1748-1757

2020

Volltextzugriff (PDF)

Metastatic melanoma concurrent to the urinary bladder and endometrium: Case report

Journal of medical imaging and radiation oncology, 2022-08, Vol.66 (5), p.643-646

2022

Volltextzugriff (PDF)

Molecular profiling of primary endometrioid endometrial cancer and matched lung metastases: CTNNB1 mutation as a potential driver

Gynecologic oncology reports, 2024-06, Vol.53, p.101391, Article 101391

2024

Volltextzugriff (PDF)

Somatic intronic TP53 c.375+5G mutations are a recurrent but under‐recognized mode of TP53 inactivation

The journal of pathology. Clinical research, 2022-01, Vol.8 (1), p.14-18

2022

Volltextzugriff (PDF)

Spectrum of BRAF Mutations and Gene Rearrangements in Ovarian Serous Carcinoma

JCO precision oncology, 2021, Vol.5 (5), p.1480-1492

2021

Volltextzugriff (PDF)

Cytomorphologic and molecular analyses of fallopian tube fimbrial brushings for diagnosis of serous tubal intraepithelial carcinoma

Cancer cytopathology, 2019-03, Vol.127 (3), p.192-201

2019

Volltextzugriff (PDF)

Advancements in Low-Grade Serous Carcinoma of the Ovary and Peritoneum

Current oncology reports, 2022-11, Vol.24 (11), p.1549-1555

2022

Volltextzugriff (PDF)

Somatic BAP1 Loss in Ovarian Serous Borderline Tumor and Recurrent Low-grade Serous Carcinoma From a Germline BAP1 Mutation Carrier

International journal of gynecological pathology, 2023-07, Vol.42 (4), p.432-433

2023

Volltextzugriff (PDF)

Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy

Clinical cancer research, 2019-09, Vol.25 (18), p.5584-5594

2019

Volltextzugriff (PDF)

Interobserver Reproducibility in Assessing Eosinophilic Cells in Ovarian Serous Borderline Tumors to Predict BRAF Mutational Status

International journal of gynecological pathology, 2023-09, Vol.42 (5), p.472-481

2023

Volltextzugriff (PDF)

MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma

Clinical cancer research, 2022-10, Vol.28 (20), p.4456-4465

2022

Volltextzugriff (PDF)

Genomic profiling identifies GPC5 amplification in association with sarcomatous transformation in a subset of uterine carcinosarcomas

The journal of pathology. Clinical research, 2018-01, Vol.4 (1), p.69-78

2018

Volltextzugriff (PDF)

High-Risk Human Papillomavirus–Associated Mixed Intestinal-Type Mucinous Adenocarcinoma and Low-grade Neuroendocrine Tumor of the Uterine Cervix: Report of a Case Harboring Shared ARID1A and SMAD4 Mutations Between Morphologically Distinct Components

International journal of gynecological pathology, 2024-09, Vol.43 (5), p.472-473

2024

Volltextzugriff (PDF)

Chromosomal Instability and mTORC1 Activation through PTEN Loss Contribute to Proteotoxic Stress in Ovarian Carcinoma

Cancer research (Chicago, Ill.), 2019-11, Vol.79 (21), p.5536-5549

2019

Volltextzugriff (PDF)

A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)

Gynecologic oncology, 2024-03, Vol.182, p.75-81

2024

Volltextzugriff (PDF)

Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors

Modern pathology, 2022-11, Vol.35 (11), p.1684-1694

2022

Volltextzugriff (PDF)

Aneuploidy Landscape in Precursors of Ovarian Cancer

Clinical cancer research, 2024-02, Vol.30 (3), p.600-615

2024

Volltextzugriff (PDF)

Folate receptor alpha expression in low-grade serous ovarian cancer: Exploring new therapeutic possibilities

Gynecologic oncology, 2024-09, Vol.188, p.52-57

2024

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(41)

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Life Sciences & Biomedicine
(40)
Humans
(33)
Female
(30)
Oncology
(22)
Pathology
(17)
Cystadenocarcinoma, Serous - Genetics
(14)
Mutation
(13)
Ovarian Neoplasms - Genetics
(12)
Ovarian Cancer
(11)
Cystadenocarcinoma, Serous - Pathology
(10)
Ovarian Neoplasms - Pathology
(10)
Obstetrics & Gynecology
(9)
Tumors
(9)
Immunohistochemistry
(8)
Aged
(6)
Neoplasm Grading
(6)
Ovarian Neoplasms - Diagnosis
(6)
Cancer
(5)
Cystadenocarcinoma, Serous - Diagnosis
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas

Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer

The highs and lows of serous ovarian cancer

Characterization of TP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinoma

Beyond the estrogen receptor: In search of predictive biomarkers for low‐grade serous ovarian cancer

Chemotherapy response in low‐grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies

Decreased HER2 expression in endometrial cancer following anti-HER2 therapy

Multi-Institutional Prospective Validation of Prognostic mRNA Signatures in Early Stage Squamous Lung Cancer (Alliance)

Metastatic melanoma concurrent to the urinary bladder and endometrium: Case report

Molecular profiling of primary endometrioid endometrial cancer and matched lung metastases: CTNNB1 mutation as a potential driver

Somatic intronic TP53 c.375+5G mutations are a recurrent but under‐recognized mode of TP53 inactivation

Spectrum of BRAF Mutations and Gene Rearrangements in Ovarian Serous Carcinoma

Cytomorphologic and molecular analyses of fallopian tube fimbrial brushings for diagnosis of serous tubal intraepithelial carcinoma

Advancements in Low-Grade Serous Carcinoma of the Ovary and Peritoneum

Somatic BAP1 Loss in Ovarian Serous Borderline Tumor and Recurrent Low-grade Serous Carcinoma From a Germline BAP1 Mutation Carrier

Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy

Interobserver Reproducibility in Assessing Eosinophilic Cells in Ovarian Serous Borderline Tumors to Predict BRAF Mutational Status

MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma

Genomic profiling identifies GPC5 amplification in association with sarcomatous transformation in a subset of uterine carcinosarcomas

High-Risk Human Papillomavirus–Associated Mixed Intestinal-Type Mucinous Adenocarcinoma and Low-grade Neuroendocrine Tumor of the Uterine Cervix: Report of a Case Harboring Shared ARID1A and SMAD4 Mutations Between Morphologically Distinct Components

Chromosomal Instability and mTORC1 Activation through PTEN Loss Contribute to Proteotoxic Stress in Ovarian Carcinoma

A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)

Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors

Aneuploidy Landscape in Precursors of Ovarian Cancer

Folate receptor alpha expression in low-grade serous ovarian cancer: Exploring new therapeutic possibilities

Aktive Filter

Suchergebnisse filtern